News

QKFXF

Amgen Buyout Reportedly Near as Onyx Pharma Sales Double in Q2

Andrew Klips | Equities.com |

San Francisco drugmaker Onyx Pharmaceuticals, Inc. (ONXX) reported second-quarter results after Thursday’s closing bell that showed a stark increase in revenue and contraction in net loss


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Steve Stanulis - Stanulis Films

Equities.com's Sam Mitchell interviewing CEO Steve Stanulis of Stanulis Films.